Carcinoma

• 

  Subject Areas on Research

  • 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. 
  • A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. 
  • A Flux Balance of Glucose Metabolism Clarifies the Requirements of the Warburg Effect. 
  • A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma. 
  • A Retrospective Study of Lymph Node Yield in Lateral Neck Dissection for Papillary Thyroid Carcinoma. 
  • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. 
  • A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress. 
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. 
  • A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. 
  • A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. 
  • A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma. 
  • A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. 
  • A phase II trial of streptozotocin and adriamycin in advanced APUD tumors. 
  • A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. 
  • ACR Appropriateness criteria® for nasopharyngeal carcinoma. 
  • ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. 
  • Abnormal parathyroid glands: high-resolution MR imaging. 
  • Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas. 
  • Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. 
  • Adenocarcinoma of the kidney. II. Enzyme histochemistry of renal adenocarcinomas induced in rats by N-(4'-fluoro-4-biphenylyl)acetamide. 
  • Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. 
  • Adnexal masses: MR imaging observations at 1.5 T, with US and CT correlation. 
  • Adrenal cortical carcinoma with vena cava tumor thrombus requiring cardiopulmonary bypass for resection. 
  • Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. 
  • Adrenocortical hyperplasia occurring with metastatic carcinoma of the prostate: report of a case exhibiting increased urinary aldosterone and glucocorticoid excretion. 
  • An expanded risk prediction model for lung cancer. 
  • An in vivo platform for translational drug development in pancreatic cancer. 
  • Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models. 
  • Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. 
  • Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression. 
  • Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. 
  • Anti-EBV serologic tests for nasopharyngeal carcinoma. 
  • Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study. 
  • Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement. 
  • Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. 
  • Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy. 
  • Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. 
  • Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma. 
  • Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. 
  • Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. 
  • Aspiration biopsy of prostate. 
  • Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). 
  • Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer. 
  • Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. 
  • Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. 
  • Atypical tubule hyperplasia and renal tubule tumors in conventional rats on 90-day toxicity studies. 
  • Avoiding complications with radical cystectomy. 
  • BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION: A CASE REPORT. 
  • Biochemical and ultrastructural differences between muco-epidermoid and carcinoid tumors of the bronchus. 
  • Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer. 
  • Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy. 
  • Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes. 
  • Bone Morphogenetic Proteins Are Expressed by Both Bone-Forming and Non-Bone-Forming Lesions. 
  • Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland. 
  • Breast carcinoma: MR imaging before re-excisional biopsy. 
  • CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. 
  • CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. 
  • Calcification in pulmonary metastases. 
  • Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation. 
  • Carcinocythemia (carcinoma cell leukemia). 
  • Carcinoma of the parathyroid gland: a 30-year experience. 
  • Carcinoma of the urethra: radiation oncology. 
  • Carcinoma of unknown primary: natural history and response to therapy. 
  • Carcinomas in children. Clinical and demographic characteristics. 
  • Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. 
  • Cell growth regulation in epithelial ovarian cancer. 
  • Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database. 
  • Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. 
  • Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer. 
  • Chylothorax: a rare complication of metastatic prostatic carcinoma. 
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. 
  • Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. 
  • Clinically localized prostatic carcinoma. 
  • Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification. 
  • Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. 
  • Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. 
  • Colon cancer. 
  • Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa. 
  • Combination chemotherapy and radiation therapy of undifferentiated small cell bronchogenic carcinoma. 
  • Comments on concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a mist of mysterious results. 
  • Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02). 
  • Compartment model approach to the estimation of tumor incidence and growth: investigation of a model of cancer latency. 
  • Complications of Bilateral Neck Dissection in Thyroid Cancer From a Single High-Volume Center. 
  • Computed tomography of the rectum. 
  • Concurrent sporadic parathyroid adenoma and carcinoma. 
  • Considerations in fractionated proton radiation therapy: clinical potential and results. 
  • Consortium analysis of 7 candidate SNPs for ovarian cancer. 
  • Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. 
  • Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. 
  • Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium. 
  • Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? 
  • Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. 
  • Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer. 
  • Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. 
  • Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. 
  • Cutaneous malignancies of the upper extremity. 
  • Cutaneous metastatic cholangiocarcinoma: a report of three cases and review of the literature. 
  • Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. 
  • Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrence. 
  • Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. 
  • Data Set for Reporting Carcinoma of the Stomach in Gastrectomy. 
  • Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. 
  • Dendritic cell vaccines targeting survivin in head and neck cancer. 
  • Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma. 
  • Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). 
  • Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. 
  • Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients. 
  • Different patterns of angiogenesis in sarcomas and carcinomas. 
  • Different strokes for different folks: new paradigms for staging oropharynx cancer. 
  • Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress. 
  • Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues. 
  • Disparities in breast carcinoma treatment in Asian/Pacific Islander women. A challenge to the provider. 
  • Distal nephron renal tumors: microsatellite allelotype. 
  • Do Histopathology and Clinical Outcomes of Breast Atypia Vary by Race/Ethnicity? 
  • Does a positive neural margin affect outcome in facial nerve grafting? 
  • Double agents in the war on cancer: leukocytes govern ovarian cancer progression. 
  • Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. 
  • Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma. 
  • Early diagnosis and treatment of medullary thyroid carcinoma. 
  • Effect of a Noise-Optimized Second-Generation Monoenergetic Algorithm on Image Noise and Conspicuity of Hypervascular Liver Tumors: An In Vitro and In Vivo Study. 
  • Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. 
  • Effect of carbon dioxide on human ovarian carcinoma cell growth. 
  • Effect of chemotherapy on uptake of alkali metals by experimental tumors. 
  • Effect of hormones on the growth of virus-transformed hamster prostatic tissue. 
  • Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. 
  • Effects of rate, volume, and dose of intratumoral infusion on virus dissemination in local gene delivery. 
  • Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis. 
  • Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. 
  • Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial. 
  • Enhanced malignant tumorigenesis in Cdk4 transgenic mice. 
  • Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. 
  • Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. 
  • Epithelial-myoepithelial carcinoma metastasis to the thoracic spine. 
  • Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. 
  • Esophageal cancer staging by CT: long-term follow-up study. 
  • Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. 
  • Etiology of the mutational spectrum of ras genes in human carcinomas. 
  • Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma. 
  • Evaluation of the paracrine and endocrine effects of genitourinary tumor produced growth factors. 
  • Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. 
  • Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. 
  • Expression of major histocompatibility complex class I antigens in normal and transformed rat thyroid epithelial cell lines. 
  • Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. 
  • Expression of proliferation-specific genes in the mucosa adjacent to colon carcinoma. 
  • Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. 
  • Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. 
  • FDG PET/CT in the management of nasopharyngeal carcinoma. 
  • Failure patterns following curative resection of colonic carcinoma. 
  • Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. 
  • Family history of cancer and risk of sporadic differentiated thyroid carcinoma. 
  • Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. 
  • Fertility drugs and ovarian cancer risk: a critical review of the literature. 
  • Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen. 
  • Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. 
  • Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. 
  • Frequent expression of human carcinoma-associated antigen, a mucin-type glycoprotein, in cells of prostatic carcinoma. 
  • GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. 
  • Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas. 
  • Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. 
  • Genetic changes in human adrenocortical carcinomas. 
  • Genetic variation in MDM2 and p14ARF and susceptibility to salivary gland carcinoma. 
  • Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. 
  • Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. 
  • Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. 
  • Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. 
  • Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. 
  • Heavy LIFting: tumor promotion and radioresistance in NPC. 
  • Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. 
  • Hemolytic anemia and metastatic carcinoma: case report and literature review. 
  • Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. 
  • Histiocytoid carcinoma of the male breast. 
  • Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study. 
  • Histotype classification of ovarian carcinoma: A comparison of approaches. 
  • Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. 
  • How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. 
  • Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. 
  • Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study. 
  • Hypophosphatemic osteomalacia: association with prostatic carcinoma. 
  • ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. 
  • Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens. 
  • Identification of novel cellular targets in biliary tract cancers using global gene expression technology. 
  • Immunoglobulin localization in benign and malignant lesions of the human mammary gland. 
  • Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. 
  • Immunoreaction at 43 kDa with anti-ubiquitin antibody in breast neoplasms. 
  • Immunotargeted nanoshells for integrated cancer imaging and therapy. 
  • Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. 
  • Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy. 
  • Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery. 
  • Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. 
  • Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma. 
  • In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma. 
  • Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. 
  • Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. 
  • Influence of ATM function on telomere metabolism. 
  • Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II. 
  • Instrumentation for multi-modal spectroscopic diagnosis of epithelial dysplasia. 
  • Integrated genomic analyses of ovarian carcinoma. 
  • Intercellular junctions and tumor behavior in lung cancer. 
  • Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. 
  • Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer. 
  • Intraoperative radiation therapy. 
  • Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. 
  • Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma. 
  • Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. 
  • Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. 
  • LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. 
  • Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. 
  • Logistic regression analysis of low grade spindle cell lesions. A cytologic study. 
  • Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. 
  • Loss of KAI1 expression in the progression of colorectal cancer. 
  • Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence. 
  • Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. 
  • Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma. 
  • Lung cancer in Florida. Risks associated with residence in the central Florida phosphate mining region. 
  • Lymph node sampling in patients with epithelial ovarian carcinoma. 
  • Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma. 
  • Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer. 
  • MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. 
  • MET and phosphorylated MET as potential biomarkers in lung cancer. 
  • MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancer. 
  • MR evaluation of adrenal masses at 1.5 T. 
  • Management of patients with concurrent primary tumors of bladder and prostate. 
  • Manganese Porphyrin and Radiotherapy Improves Local Tumor Response and Overall Survival in Orthotopic Murine Mammary Carcinoma Models. 
  • Merkel cell carcinoma of the eyelid. 
  • Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. 
  • Metformin prevents tobacco carcinogen--induced lung tumorigenesis. 
  • Mitochondrial DNA alterations in thyroid cancer. 
  • Mixed Connective Tissue Disease and Papillary Thyroid Cancer: A Case Report. 
  • Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy. 
  • Molecular classification of human carcinomas by use of gene expression signatures. 
  • Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping. 
  • Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. 
  • Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine. 
  • Mucoepidermoid carcinoma of the esophagus: a case report. 
  • Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. 
  • Mutations of the E-cadherin gene in human gynecologic cancers. 
  • Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. 
  • NCCN Clinical Practice Guidelines Occult primary. 
  • NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. 
  • NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network. 
  • NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system. 
  • Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. 
  • Neck masses: illustration of a logical approach. 
  • New and emerging therapies for bone metastases in genitourinary cancers. 
  • Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results. 
  • Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. 
  • Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. 
  • Non-randomized comparative study of irradiation alone or in combination with surgery in stage Ib, IIa and "proximal" IIb carcinoma of the cervix. 
  • Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. 
  • Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice. 
  • OVX1 as a marker for early stage endometrial carcinoma. 
  • Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma. 
  • Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women. 
  • Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. 
  • PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. 
  • Paleo-oncology: the role of ancient remains in the study of cancer. 
  • Pancreatic FNA in 1000 cases: a comparison of imaging modalities. 
  • Pathogenesis of ovarian cancers. 
  • Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. 
  • Pathology of epithelial ovarian tumors. 
  • Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse. 
  • Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer. 
  • Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. 
  • Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer. 
  • Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma. 
  • Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. 
  • Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. 
  • Phase II trial of fazarabine in advanced colorectal carcinoma. 
  • Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study. 
  • Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment. 
  • Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck. 
  • Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. 
  • Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma? 
  • Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. 
  • Postfreeze viability of human renal epithelial carcinoma cells related to phase transformations in ternary solutions. 
  • Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. 
  • Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy. 
  • Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. 
  • Preoperative and postoperative CT staging of rectosigmoid carcinoma. 
  • Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. 
  • Preoperative irradiation for tethered rectal carcinoma. 
  • Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. 
  • Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer. 
  • Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population. 
  • Primary pancreatic lymphoma evaluated by fine-needle aspiration: findings in 14 cases. 
  • Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania. 
  • Prognostic significance of DNA ploidy in carcinoma of prostate. 
  • Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). 
  • Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. 
  • Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. 
  • Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism. 
  • Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. 
  • Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes. 
  • RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. 
  • Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. 
  • Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. 
  • Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function. 
  • Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. 
  • Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. 
  • Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule. 
  • Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. 
  • Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. 
  • Relation between p53 overexpression and established prognostic factors in breast cancer. 
  • Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. 
  • Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines. 
  • Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. 
  • Response to the Letter by Katiman E., et al. 
  • Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic? 
  • Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels. 
  • Role of 18 F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. 
  • Role of ABL family kinases in cancer: from leukaemia to solid tumours. 
  • SET8 Inhibition Potentiates Radiotherapy by Suppressing DNA Damage Repair in Carcinomas. 
  • Second malignant neoplasms of the head and neck in survivors of retinoblastoma. 
  • Selection and validation of endogenous reference genes using a high throughput approach. 
  • Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. 
  • Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. 
  • Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy. 
  • Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. 
  • Solitary spinal metastasis of Hürthle cell thyroid carcinoma. 
  • Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. 
  • Sonography of benign cystic teratoma of the ovary: pitfalls in diagnosis. 
  • Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy. 
  • Spindle-cell lesions of the liver: diagnosis by fine-needle aspiration biopsy. 
  • Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. 
  • Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic carcinoma. 
  • Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. 
  • Suppression of human corneal epithelial proliferation with breast carcinoma immunotoxin. 
  • Suppressor of fused negatively regulates beta-catenin signaling. 
  • Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cm. 
  • Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. 
  • Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma. 
  • Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. 
  • T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma. 
  • Tamoxifen in postmenopausal women a safety perspective. 
  • Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma. 
  • Targeting slow-proliferating ovarian cancer cells. 
  • Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. 
  • The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories. 
  • The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications. 
  • The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. 
  • The combination of TPL2 knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines. 
  • The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. 
  • The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. 
  • The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats. 
  • The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. 
  • The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. 
  • The natural course of prostatic carcinoma in relation to initial cytological grade. 
  • The pelvis after surgery for rectal carcinoma: serial CT observations with emphasis on nonneoplastic features. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. 
  • The prognostic significance of angiogenesis in epithelial ovarian carcinoma. 
  • The role of lymphoscintigraphy in the management of the patient with breast cancer. 
  • The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. 
  • The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. 
  • The secondary pulmonary lobule: normal and abnormal CT appearances. 
  • The significance of enlarged cervical lymph nodes in diagnosing thyroid cancer. 
  • Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation. 
  • Timing of weight gain and breast cancer risk. 
  • Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. 
  • Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1. 
  • Transplanted carcinoma in an immunosuppressed patient. 
  • Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. 
  • Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. 
  • Treatment patterns and costs associated with sessile colorectal polyps. 
  • Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma. 
  • Tuboovarian abscess in postmenopausal women. 
  • Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. 
  • Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. 
  • Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. 
  • Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology. 
  • Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. 
  • Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer. 
  • Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. 
  • Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. 
  • Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. 
  • Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families. 
  • Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer. 
  • Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. 
  • Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. 
  • What Is the Optimal Treatment of Papillary Thyroid Cancer? 
  • Whole-Genome and Segmental Homozygosity Confirm Errors in Meiosis as Etiology of Struma Ovarii. 
  • Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma. 
  • Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. 
  • X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. 
  • p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. 
  • p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology